<unk>  human-tvmh is indicated for the treatment of people with<unk> deficiency type 1, also referred to as hypoplasminogenemia, a disorder that can impair normal tissue and organ function and may lead to blindness.
Plasminogen 
Thrombin
Fibrinogen
Platelet-activating factor
Hemostat
Prothrombinase
Serpin
Platelet-rich fibrin